Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Ottawa

$362,847.00

Rapid nanopore-based single molecule counting for accurate concentration measurements

FY 2019-20

Summary
Scientific instrumentation for Health and Life sciences, particularly diagnostics, is undergoing a revolution. New technologies have emerged that can interrogate individual molecules to enable important new opportunities in healthcare. Further progress toward the era of precision medicine requires the realization of two critical criteria. First, new tools will require ultrasensitivity, to enable detection of just a few copies of a target biomarker in a sample. Second, since the benefit of ultrasensitivity leading to early detection can be lost if the results are delayed and the opportunity to use those results for timely intervention is missed, these tools must also democratize detection, moving from a traditional centralized core lab to more rapid, mobile, low-cost testing on site. Nanopore sensing is the most promising emerging ultrasensitive technology that is amenable to decentralization. Nanopores are inherently single molecule detectors and are entirely electrical in nature, with no need for complex, expensive, and bulky optical components and dyes. As such, they are uniquely suited to provide ultrasensitive detection in a miniaturized, portable and decentralized format.In this proposal, we will address the main 'control points' that would enable the development of an ultrasensitive nanopore-based immunoassay technology amenable to the point of care, by increasing the counting speed of individual molecules to lower the limit of detection for accurate quantification of biomarkers. This project is highly interdisciplinary and uniquely positioned to advance the nanopore sensing field, and to strengthen the Canadian stake in this emerging area and in the larger nanobiotechnologies sector. Many students will be exposed to the challenges of collaboratively developing advanced technology for a rapidly-evolving market. The Canadian economy will also directly benefit as this and future innovations will be commercialized by our partner and other industry players. With this project, Canadians can look forward to better, faster, more precise, and more convenient healthcare, especially in remote settings.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
530554-2018
Name nom
TabardCossa, Vincent
Department département
Physics
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
362847
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
141
Committee name en
University/Industry
Committee name fr
Universités/industrie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1 - 2
Partie
1
Nb partie
2
Application title
Rapid nanopore-based single molecule counting for accurate concentration measurements
Keyword
NSERC
Application summary
Scientific instrumentation for Health and Life sciences, particularly diagnostics, is undergoing a revolution. New technologies have emerged that can interrogate individual molecules to enable important new opportunities in healthcare. Further progress toward the era of precision medicine requires the realization of two critical criteria. First, new tools will require ultrasensitivity, to enable detection of just a few copies of a target biomarker in a sample. Second, since the benefit of ultrasensitivity leading to early detection can be lost if the results are delayed and the opportunity to use those results for timely intervention is missed, these tools must also democratize detection, moving from a traditional centralized core lab to more rapid, mobile, low-cost testing on site. Nanopore sensing is the most promising emerging ultrasensitive technology that is amenable to decentralization. Nanopores are inherently single molecule detectors and are entirely electrical in nature, with no need for complex, expensive, and bulky optical components and dyes. As such, they are uniquely suited to provide ultrasensitive detection in a miniaturized, portable and decentralized format.In this proposal, we will address the main 'control points' that would enable the development of an ultrasensitive nanopore-based immunoassay technology amenable to the point of care, by increasing the counting speed of individual molecules to lower the limit of detection for accurate quantification of biomarkers. This project is highly interdisciplinary and uniquely positioned to advance the nanopore sensing field, and to strengthen the Canadian stake in this emerging area and in the larger nanobiotechnologies sector. Many students will be exposed to the challenges of collaboratively developing advanced technology for a rapidly-evolving market. The Canadian economy will also directly benefit as this and future innovations will be commercialized by our partner and other industry players. With this project, Canadians can look forward to better, faster, more precise, and more convenient healthcare, especially in remote settings.
University of Ottawa - $362,847 Grant (2019-20) | Canada Spends